MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Perinatal Dioxin Exposure and Dopaminergic Vulnerability in the Development of Motor Dysfunction Sequelae

N. Choudhury, S. Shugar, B. Carr (Gainesville, USA)

Meeting: 2025 International Congress

Keywords: Dopaminergic neurons, Environmental toxins, Motor control

Category: Drug-Induced Movement Disorders

Objective: To investigate the impact of dioxins on movement disorder development and the mechanisms increasing vulnerability to future motor dysfunction.

Background: Dioxins are persistent organic pollutants that act via the aryl hydrocarbon receptor (AhR) pathway, which is implicated in nigrostriatal damage, oxidative stress, and neuroinflammation. Dioxins have the potential to disrupt dopaminergic neuron development with potential long-term consequences for basal ganglia function and movement disorders. This review synthesizes evidence linking perinatal exposure to dioxins to dopamine system dysfunction, dystonia, and early-onset Parkinsonian features.

Method: A narrative review of longitudinal cohort studies and animal experimental neurotoxicological research was conducted which evaluated perinatal dioxin exposure levels and association with  motor development (rigidity, bradykinesia, tremor and dystonic features), neuroimaging/electrophysiological evidence of altered basal ganglia function following early-life exposure, and insights from animal models that link AhR activation to persistent dysfunction in the dopaminergic system and increased susceptibility to Parkinson’s disease.

Results: Evidence linking dioxin exposure to movement disorders is mixed. Some cohort studies report high perinatal exposure correlates with motor coordination impairments and altered striatal dopamine receptor density, particularly in male offspring. However, other longitudinal studies find no significant association with later-life motor dysfunction, suggesting resilience mechanisms. Animal studies show high-dose perinatal dioxin exposure induces persistent dopaminergic dysfunction, but effects vary by dose and species. The role of confounders, such as co-exposure to neurotoxicants (e.g., heavy metals, pesticides) and genetic predispositions, remains underexplored in human studies.

Conclusion: Preclinical data suggest high-dose perinatal dioxin exposure can disrupt dopaminergic signaling and increase neurodegeneration risk, but epidemiological evidence does not confirm a definitive causal link to human movement disorders. Given dioxins’ environmental persistence, ongoing monitoring of exposure and neurodevelopmental effects is warranted.

To cite this abstract in AMA style:

N. Choudhury, S. Shugar, B. Carr. Perinatal Dioxin Exposure and Dopaminergic Vulnerability in the Development of Motor Dysfunction Sequelae [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/perinatal-dioxin-exposure-and-dopaminergic-vulnerability-in-the-development-of-motor-dysfunction-sequelae/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/perinatal-dioxin-exposure-and-dopaminergic-vulnerability-in-the-development-of-motor-dysfunction-sequelae/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley